Skip to main content
Intermediate Technical IVT

inotropic support

The use of medications to enhance cardiac contractility in patients with heart failure or cardiogenic shock.

Full Definition

Inotropic support refers to the therapeutic use of pharmacological agents that increase myocardial contractility to improve cardiac output in patients with acute or chronic heart failure. Common inotropic agents include dobutamine, milrinone, and dopamine, each with distinct mechanisms of action and hemodynamic profiles. These medications are typically reserved for hospitalized patients with severe systolic dysfunction or cardiogenic shock, as they may increase oxygen demand and arrhythmia risk. Duration and choice of agent depend on clinical scenario, renal function, and hemodynamic goals.

Usage

Usage note: Specify the agent used (e.g., 'dobutamine inotropic support') when possible.

In Context

  • "The patient required inotropic support with dobutamine to maintain adequate cardiac output." — ICU progress note
  • "Weaning of inotropic support was attempted on hospital day 5 but resulted in clinical decompensation." — Heart failure hospitalization summary

Also known as

inotropic therapy positive inotropic support

Don't confuse with

vasopressor support mechanical circulatory support

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON